DOLF Sponsored

Rao RU, Samarasekera SD, Nagodavithana KC, Puhchihewa MW, Ranasinghe USB, Weil GJ. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka
PLoS Negl Trop Dis 2019 in press

Edi C, Bjerum CM, Koudou BG, Chhonker YS, Penali LK, Meite A, Ouattara AF, Weil GJ, King CL, and Murry DJ. Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d’Ivoire
PLoS Negl Trop Dis 2019  in press

Chenais CB, Awaca-Uvon NP, Vlaminck J, Tambwe JP, Weil GJ, Pion SD, Boussinesq M. Risk factors for lymphatic filariasis in two villages of the Democratic Republic of the Congo
Parasites & Vectors, 2019; 12:162

A comparison of the impact of annual and semiannual mass drug administration on lymphatic filariasis prevalence in Flores Island, Indonesia
T Supali, Y Djuardi, A Lomiga,  SN Linda, E Iskander, CW Goss, JP Miller, GJ Weil, PU Fischer
Am J Trop Med Hyg 100(2)336-343 (2019)

A Trial of a Triple-Drug Treatment for Lymphatic Filariasis
CL King, J Suamani, N Sanuku, YC Cheng, S Satofan, B Mancuso, CW Goss, LJ Robinson, PM Siba, GJ Weil, JW Kazura
N Engl J Med 379(19) 1801-1810 (2018)

 Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature
PJ Budge, C Herbert, BJ Andersen, GJ Weil
PLoS Negl Trop Dis, 12(5) (2018)

Capillaria Ova and Diagnosis of Trichuris trichiura Infection in Humans by Kato-Katz Smear, Liberia
K Fischer, A Gankpala, L Gankpala, FK Bolay, KC Curtis, GJ Weil, PU Fischer
Emerg Infect Dis, 24(8), 1551-1554 (2018)

Identification and characterization of Loa loa antigens responsible for cross-reactivity with rapid diagnostic tests for lymphatic filariasis
MI Hertz, H Nana-Djeunga, J Kamgno, A Jelil Njouendou, V Chawa Chunda, S Wanji, PJ Budge
PLoS Negl Trop Dis, 12(11) (2018)

Update on the current status of onchocerciasis in Cote d’Ivoire following 40 years of intervention: Progress and challenges
BG Koudou, MM, Kouakou, AF Ouattara, S Yeo, P Brika, A Meite, PU Fischer
PLoS Negl Trop Dis, 12(10) (2018)

Comprehensive assessment of a hotspot with persistent bancroftian filariasis in coastal Sri Lanka
RU Rao, SD Samarasekera, KC Nagodavithana, TDM Dassanayaka, MW Punchihewa, USB Ranasinghe, GJ Weil
Am J Trop Med Hyg: 99:735-742 (2018)

Changes in cytokine, filarial antigen, and DNA levels associated with adverse events following treatment of lymphatic filariasis
BJ Andersen, J Kumar, K Curtis, N Sanuku, S Satafan, CL King, PU Fischer, GJ Weil
J. Infec. Dis. 217: 280- 287(2018)

Differential human gut microbiome assemblages during soil-transmitted helminth infections in Indonesia and Liberia
BA Rosa, T Supali, L. Gankpala, Y Djuardi, E Sartono, Y Zhou, K Fischer, J Martin, R Tyagi, FK Bolay, PU Fischer, M Yazdanbakhsh, M Mitreva
Microbiome 6(33)(2018)

Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka
RU Rao, SD Samarasekera, DC Nagodavithana, TDM Dassanayaka, MW Punchihewa, USB Ranasinghe, GJ Weil.
PLoS Negl. Trop. Dis. 11: e0006066 (2017)

A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa
CB Chesnais, NP Awaca-Uvon, FK Bolay, M Boussinesq, PU Fischer, L Gankpala, A Meite, F Missamou, SD Pion, GJ Weil
PLoS Negl.Trop. Dis. 11(9): 1-15 (2017)

Effect of 3 years of biannual mass drug administration with albendazole on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in Republic of the Congo
SDS Pion, CB Chenaiz, GJ Weil, PU Fischer, F Missamou, M Boussinesq
Lancet Infect Dis. 17(7):763-769 (2017)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa
PU Fischer, CL King, JA Jacobson, GJ Weil
PLoS Negl. Trop. Dis. 11(1): 1-10 (2017)

Use of a novel portable 3D scanner to measure limb volume and circumference in patients with filarial lymphedema
C Yahathugoda, M Weiler, R Rao, L De Silva, J Dixon, M Weerasooriya, GJ Weil, P Budge
Am J Trop Med Hyg 97:1836-1842 (2017)

Effectiveness of a Triple-Drug Regimen for Global Elimination of Lymphatic Filariasis: A Modelling Study
MA Irvine, WA Stolk, ME Smith, S Subramanian, BK Singh, GJ Weil, E Michael, TD Hollingsworth
Lancet Infect. Dis. 17(4):451-458 (2016)

Measurement of Circulating Filarial Antigen Levels in Human Blood with a Point-of-Care Test Strip and a Portable Spectrodensitometer
CB Chesnais, J Vlaminck, B Kunyu-Shako, SD Pion, NP Awaca-Uvon, GJ Weil, D Mumba, M Boussinesq
Am. J. Trop. Med. Hyg. 94(6):1324-1329 (2016)

Familial aggregation and heritability of Wuchereria bancrofti infection
CB Chesnais, A Sabbagh, SD Pion, F Missamou, A Garcia, MJ Boussinesq
JID 214:587-594 (2016)

Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri Lanka
RU Rao, SD Samarasekera, KC Nagadavithana, MW Punchilewa, TDM Dassanayaka, Gamini PKD, E Ford, Udaya S, B Ranassinghe, RH Henderson, GJ Weil
PLoS Neglected Trop. Dis. 10(5):1-16 (2016)

Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis
EK Thomsen, N Sanuku, M Baea, S Satofan, E Maki, B. Lombore, MS Schmidt, PM Siba, GJ Weil, JW Kazura, LL Fleckenstein, CL King
Clinical Infectious Diseases 62(3):334-41 (2016)

Community Attitudes Toward Mass Drug Administration for Control and Elimination of Neglected Tropical Diseases After the 2014 Outbreak of Ebola Virus Disease in Lofa County, Liberia
J Bogus, L Gankpala, K Fischer, A Krentel, GJ Weil, PU Fischer, K Kollie, FK Bolay
Am J Trop Med Hyg  2;94(3):497-503 (2016)

A Comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration
TC Yahathugoda, T Supali, RU Rao, Y Djuardi, D Stefani, F Pical, PU Fischer, MM Lloyd, PH Premaratne, MV Weerasooriya, GJ Weil
Parasites & Vectors 8:369 (2015)

The Impact of Two Semi-annual Treatments with Albendazole Alone on Lymphatic Filariasis and Soil-Transmitted Helminth Infections: A Community-based Study in the Republic of Congo
SDS Pion, CB Chesnais, J Bopda, F Louya, PU Fischer, AC Majewski, GJ Weil, M Boussinesq, F Missamou
Am J Trop Med Hyg 92(5):959-966 (2015)

Conventional parasitology and DNA-based diagnostic methods for onchocerciasis elimination programmes
MM Lloyd, R Gilbert, NT Taha, GJ Weil, A Meite, IMM Kouakou, PU Fischer
Acta Trop 146:114-118 (2015)

Diagnostic tools for onchocerciasis elimination programs
J Vlaminck, PU Fischer, GJ Weil
Trends in Parasitology 31:571-82 (2015)

Filarial Antigenemia and Loa loa Night Blood Microfilaremia in an Area Without Bancroftian Filariasis in the Democratic Republic of Congo
DK Bakajika, MM Nigo, JP Lotsima, GA Masikini, K Fischer, MM Lloyd, GJ Weil, PU Fischer
Am J. Trop. Med. Hyg. 91(6):1142-1148 (2014)

A case study of risk factors for LF in the Republic of Congo
CB Chesnais, F Missamou, SD Pion, J. Bopda, F Louya, AC Majewski, PU Fischer, GJ Weil, M Boussinesq
Parasites & Vectors 7:300 (2014)

A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration
RU Rao, KC Nagodavithana, SD Samarasekera, AD Wijegunawardana, WDY Premakumara, SN Perera, S Settinayake, JP Miller, GJ Weil
PLoS NTD 8(11):e3281 (November 2014)

Liquid chromatography-mass spectrometry analysis of diethylcarbamazine in human plasma for clinical pharmacokinetic studies
MS Schmidt, CL King, EK Thomsen, PM Siba, N Sanuku, L Fleckenstein
J Pharm. Biomed. Anal. 98:307-10 (September 2014)

Exploring the potential of flubendazole in filariasis control: Evaluation of the systemic exposure for different pharmaceutical preparations
L Ceballos, C Mackenzie, T Geary, L Alvarez, C Lanusse
PLoS NTD 8(5):e2838 (May 2014)

Integrated school-based surveillance for soil-transmitted helminth infections and lymphatic filariasis in Gampaha District, Sri Lanka
S Gunawardena, NK Gunawardena, G Kahathuduwa, ND Karunaweera, NR de Silva, UB Ranasinghe, SD Samarrasekara, KC Nagodavithana, RU Rao, MP Rebollo, GJ Weil
Am J. Trop. Med. Hyg. 90(4):661-666 (2014)

Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen
CB Chesnais, F Missamou, SDS Pion, J Bopda, F Louya, AC Majewski, GJ Weil, M Boussinesq
Am. J. Trop. Med. Hyg. 89(5):916-918 (2013)

A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis
A Krentel, PU Fischer, GJ Weil
PLoS NTD 7(11):e2447 (November 2013)

Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood
GJ Weil, KC Curtis, L Fakoli, K Fischer, L Gankpala, PJ Lammie, AC Majewski, S Pelletreau, KY Won, FK Bolay, PU Fischer
Am. J. Trop. Med. Hyg. 89(1):11-15 (2013)

Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis
WA Stolk, QA ten Bosch, SJ de Vlas, PU Fischer, GJ Weil, AS Goldman
PLoS NTD 7(1):e1984 (January 2013)

A review of flubendazole and its potential as a macrofilariacide
C Mackenzie
A report submitted to Dr. Gary Weil (PI DOLF) – a study supported by the Bill & Melinda Gates Foundation

Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs
CD Mackenzie, TG Geary
Expert Rev. Anti Infect. Ther. 9(5):497-501 (2011)